ABSTRACT:Glucuronidation not only plays a detoxifying role in living body, but it also can complicate pharmacological and toxicological profiles of new drug candidates by forming active and reactive conjugated metabolites. The opportunity to elucidate structure of conjugated metabolites has increased in drug metabolism studies at the early development stage. General methodologies for the structure elucidation of glucuronide conjugate(s) include liquid chromatography-tandem mass spectrometry (LC-MS/MS) and NMR spectroscopy. In many cases, LC-MS/MS alone cannot unequivocally identify the site(s) of conjugation in isomeric glucuronidations. In the present study, we established a new strategy for the structure elucidation of glucuronide conjugates using ion mobility spectrometry (
IntroductionGlucuronide conjugation is one of the main phase II metabolic reactions in the living body. The addition of glucuronic acid to the structure of xenobiotics through UGT-dependent glucuronidation makes the compounds more hydrophilic and less active pharmacologically and/or toxicologically, and the resultant conjugated metabolites are eliminated into bile and urine. In general, the glucuronide conjugation had been considered to be an important detoxifying pathway in most cases associated with rapid excretion and small volume of distribution; however, it has been demonstrated that the glucuronidation can also form active and/or reactive conjugated metabolites that modulate pharmacological, toxicological, or pharmacokinetic profiles of parent compounds (Shipkova and Wieland, 2005;Regan et al., 2010). For example, morphine-6-glucuronide (van Dorp et al., 2006), digitoxin-and digoxin-glucuronides, retinoic acid glucuronide (Kroemer and Klotz, 1992;Ritter, 2000), and ezetimibe glucuronide (Patrick et al., 2002) are known to maintain or increase the pharmacological activities of parent drugs. The formation of acyl glucuronide has been implicated in a wide range of adverse effects, including drug hypersensitivity reactions and cellular toxicity (Ritter, 2000), and the chemical reactivity depends on the stability of acyl glucuronide conjugate (Benet et al., 1993). In an example of the pharmacokinetic effect by glucuronide conjugate, it has been demonstrated that the gemfibrozil glucuronide is a mechanism-based CYP2C8 inhibitor in humans (Baer et al., 2009;Honkalammi et al., 2011;Jenkins et al., 2011). Therefore, the structure identification of glucuronide conjugates is often required at the early development stage of new drug candidates.Because of its high sensitivity and ability to obtain structural information, the liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become an invaluable tool in drug metabolism studies. LC-MS/MS can readily detect glucuronide conjugates based on an increase of 176 Da over the parent compound and major mass fragments corresponding to the neutral loss of the glucuronyl moiety. However, when multiple sites are potential for the glucuronidation, the determination of exact site requires further exp...